Knott David M Jr - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Knott David M Jr ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$190
-49.7%
557,939
-33.6%
0.08%
-47.6%
Q4 2022$378
-100.0%
840,000
-6.7%
0.14%
-57.1%
Q3 2022$792,000
+68.5%
900,000
+120.1%
0.33%
+69.0%
Q2 2022$470,000
+968.2%
408,953
+1529.3%
0.20%
+1307.1%
Q1 2022$44,00025,1000.01%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 2,664,400$2,345,0002.45%
Key Client Fiduciary Advisors, LLC 1,120,943$986,0000.89%
Knott David M Jr 900,000$792,0000.33%
ACT CAPITAL MANAGEMENT, LLC 265,000$233,0000.32%
Perceptive Advisors 7,472,148$6,575,0000.19%
Tri Locum Partners LP 711,798$626,0000.17%
683 Capital Management, LLC 2,265,000$1,993,0000.15%
Artal Group S.A. 4,000,000$3,520,0000.15%
TANG CAPITAL MANAGEMENT LLC 1,250,000$1,100,0000.14%
HealthCor Management, L.P. 1,066,689$939,0000.12%
View complete list of LEAP THERAPEUTICS INC shareholders